Injectable Disease Modifying Agents in Multiple Sclerosis: Pattern of Medication Use and Clinical Effectiveness. Järvinen E, Holmberg M, Sumelahti M-L Neurol Int. 2016 Sep 30; 8(3):6513. PMID: 27761226. Abstract CommentRecommendBookmarkWatch
